Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply

Authors :: Sara, Rundquist
Michael C, Sachs
Carl, Eriksson
Ola, Olén
Scott, Montgomery
Jonas, Halfvarson
Source :: Alimentary pharmacologytherapeuticsREFERENCES. 53(5)
Publication Year :: 2021

Subjects :: Sweden
Pharmaceutical Preparations
Tumor Necrosis Factor-alpha
Humans
Antibodies, Monoclonal, Humanized
Inflammatory Bowel Diseases

Tools